The IBC is responsible for reviewing projects in which biohazards are used ensuring that research is conducted safely and that risks are assessed and minimized – see IBC Charge. The IBC reviews and approves projects and issues Biohazard Use Authorization (BUA) permits per the standard operating procedure: SOP IBC BUA Review and Approval Process. Visit the Biohazard Use Authorization (BUA) web page to register, renew, or amend a BUA.

Additionally, Human Gene Transfer (HGT) clinical trials need to be reviewed by an IBC. Before HGT clinical trials can commence, the study teams need to fulfill a specific set of requirements before they can be approved by the IBC. Read more about the IBC approval process for HGT clinical trials.

IBC Deadlines and Meeting Dates

Protocol Submission DeadlineIBC Meeting DatesZoom
January 4, 2024January 25, 2024Zoom>>
February 8, 2024February 29, 2024SBA 329 or Zoom>>
March 7, 2024March 28, 2024Zoom>>
April 4, 2024April 25, 2024Zoom>>
May 9, 2024May 30, 2024SBA 329 or Zoom>>
June 6, 2023June 27, 2024Zoom>>
July 25, 2024Zoom>>
August 8, 2024August 29, 2024SBA 329 or Zoom>>
September 5, 2024September 26, 2024Zoom>>
October 10, 2024October 31, 2024Zoom>>
October 31, 2024November 21, 2024SBA 329 or Zoom>>
December 19, 2024Zoom>>